Stay updated on Oral Voxelotor in Sickle Cell Disease Clinical Trial
Sign up to get notified when there's something new on the Oral Voxelotor in Sickle Cell Disease Clinical Trial page.

Latest updates to the Oral Voxelotor in Sickle Cell Disease Clinical Trial page
- Check5 days agoChange DetectedHb SS disease is listed as a related term; Genetic and Rare Diseases Information Center is added as a resource.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page displays Revision: v3.5.0, replacing Revision: v3.4.3.SummaryDifference0.0%

- Check26 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed from the page.SummaryDifference0.0%

- Check54 days agoChange DetectedAdded Revision: v3.4.2. Removed the earlier notices about government funding interruptions and operating status (Revision: v3.4.1).SummaryDifference0.3%

- Check61 days agoChange DetectedAdded a government-funding lapse notice at the top of the page. Updated the site to revision v3.4.1, replacing v3.4.0.SummaryDifference0.3%

- Check69 days agoChange DetectedAdded UI/metadata updates: a 'Show glossary' toggle, the QC label 'Last Update Submitted that Met QC Criteria', the 'No FEAR Act Data' notice, and the revision tag 'Revision: v3.4.0' (replacing the older lowercase label, 'No FEAR Act data', and 'Revision: v3.3.4').SummaryDifference0.1%

Stay in the know with updates to Oral Voxelotor in Sickle Cell Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Voxelotor in Sickle Cell Disease Clinical Trial page.